Markov Chain Monte Carlo simulation for projection of end stage renal disease patients in Greece

Computer Methods and Programs in Biomedicine

Volumn 107, Issue 1, 2012, Pages 90-96

  Rodina Theocharaki, A ^a   Bliznakova, K ^a   Pallikarakis, N ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

End stage renal disease; Markov Chain; Monte Carlo simulation

Indexed keywords

CHRONIC CONDITIONS; COST EFFECTIVENESS ANALYSIS; END STAGE RENAL DISEASE; END-STAGE RENAL DISEASE PATIENTS; HEALTH CARE PROVIDERS; HEMODIALYSIS PATIENT; KIDNEY TRANSPLANTATION; MARKOV CHAIN MONTE CARLO SIMULATION; MONTE CARLO SAMPLING TECHNIQUE; MONTE CARLO SIMULATION; QUALITY OF LIFE; RENAL REPLACEMENT THERAPIES; RESOURCE MANAGEMENT; TREATMENT METHODS;

DIALYSIS; DISEASES; FORECASTING; MARKOV PROCESSES; PATIENT TREATMENT; PROBABILITY DISTRIBUTIONS;

MONTE CARLO METHODS;

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; GREECE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; PROBABILITY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ALGORITHMS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; GREECE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MARKOV CHAINS; MIDDLE AGED; MODELS, ECONOMIC; MONTE CARLO METHOD; RENAL DIALYSIS;

EID: 84861196546     PISSN: 01692607     EISSN: 18727565     Source Type: Journal    
DOI: 10.1016/j.cmpb.2011.09.012     Document Type: Article

References (18)

1. The United States Renal Data System, Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. (accessed 15.03.11). http://www.usrds.org/adr.htm.
2. Hakkarainen P., Kapanen S., Honkanen E., Löflund E. Long slow night hemodialysis and quality of life. Hemodialysis International 2005, 9:97.
3. Stavrianou K., Pallikarakis N. Quality of life of end-stage renal disease patients and study on the implementation of nocturnal home hemodialysis in Greece. Hemodialisys International 2007, 11:204-209.
4. Mallick N.P. The costs of renal services in Britain. Nephrology Dialysis Transplantation 1997, (Suppl 1):25-28.
5. Roberts S.D., Maxwell D.R., Gross T.L. Cost-effective care of end-stage renal disease: a billion dollar question. Annals of Internal Medicine 1980, 92:243-248.
6. Kaitelidou D., Ziroyanis P.N., Maniadakis N., Liaropoulos L.L. Economic evaluation of hemodialysis: implications for technology assessment in Greece. International Journal of Technology Assessment in Health Care 2005, 21:40-46.
7. Kontodimopoulos N., Niakas D. An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy. Health Policy 2008, 86:85-96.
8. Rodina A., Bliznakova K., Stavrianou R. Prevalence prognosis of the end stage renal disease patients in Greece. WC 2009 World Congress on Medical Physics and Biomedical Engineering, 2009, Munich, Germany IFMBE Proceedings 2009.
9. European Renal Association and European Dialysis and Transplant Association reports. (accessed 15.03.11). http://www.era-edta-reg.org/index.jsp%3Fp=14.
10. Ioannidis G., Papadaki O., Tsakiris D. Statistical and epidemiological data of the renal replacement therapy in Greece. Report of the Hellenic Renal Registry. Hellenic Nephrology 2002, 14:525-548.
11. Kirby L., Vale L. Dialysis for end-stage renal disease. Determining a cost-effective approach. International Journal of Technology Assessment in Health Care 2001, 17:181-189.
12. Schaubel D., Morrison H., Fenton S.S. Projecting renal replacement therapy-specific end-stage renal disease prevalence using registry data. Kidney International 2000, 74(Suppl.):S49-S54.
13. Teerawattananon Y., Mugford M., Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value in Health 2007, 10:61-72.
14. Vestergaard P., Lokkegaard H. Predicting future trends in the number of patients on renal replacement therapy in Denmark. Nephrology Dialysis Transplantation 1997, 12:2117-2123.
15. Finnish registry of kidney disease Reports. (accessed 15.03.11). http://www.musili.fi/fin/munuaistautirekisteri/finnish_registry_for_kidney_diseases/.
16. Beck J.R., Pauker S.G. The Markov process in medical prognosis. Medical Decision Making 1983, 3:419-458.
17. De Wit G.A., Ramsteijn P.G., De Charro F.T. Economic evaluation of end stage renal disease treatment. Health Policy 1998, 44:215-232.
18. Howard K., Salkeld G., White S., Mcdonald S., Chadban S., Craig J.C., Cass A. The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology 2009, 14:123-132.